Theriva Biologics, Inc. Repayments of Long-Term Debt
Theriva Biologics, Inc. (TOVX) reported Repayments of Long-Term Debt of $56.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2025-05-14
- Theriva Biologics, Inc. repayments of long-term debt for the quarter ending 2025-03-31 was $56.00K.
- Theriva Biologics, Inc. repayments of long-term debt for the quarter ending 2024-12-31 was $0.00.
- Theriva Biologics, Inc. repayments of long-term debt for the quarter ending 2024-09-30 was $0.00.
- Theriva Biologics, Inc. repayments of long-term debt for the quarter ending 2023-12-31 was $0.00.
- Theriva Biologics, Inc. repayments of long-term debt for fiscal 2024 was $67.00K, a 10.67% decline from fiscal 2023.
- Theriva Biologics, Inc. repayments of long-term debt for fiscal 2023 was $75.00K, a 94.55% decline from fiscal 2022.
- Theriva Biologics, Inc. repayments of long-term debt for fiscal 2022 was $1.38M.
- Theriva Biologics, Inc. repayments of long-term debt for fiscal 2021 was $0.00.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2025-03-31 | $56.00K 10-Q · filed 2025-05-14 | $56.00K derived: sum of 2 quarters · filed 2025-05-14 | $56.00K derived: sum of 3 quarters · filed 2025-05-14 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $0.00 derived: sum of 2 quarters · filed 2025-03-06 | $67.00K 10-K · filed 2025-03-06 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $67.00K 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | $67.00K 10-Q · filed 2024-08-13 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $0.00 derived: sum of 2 quarters · filed 2025-03-06 | $20.00K derived: sum of 3 quarters · filed 2025-03-06 | $75.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $20.00K derived: sum of 2 quarters · filed 2024-11-12 | $75.00K 10-Q · filed 2024-11-12 | $75.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $75.00K 10-Q · filed 2024-08-13 | $75.00K derived: sum of 3 quarters · filed 2024-08-13 | $75.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $55.00K 10-Q · filed 2024-05-07 | $55.00K derived: sum of 2 quarters · filed 2024-05-07 | $55.00K derived: sum of 3 quarters · filed 2024-05-07 | $55.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $0.00 derived: sum of 2 quarters · filed 2024-03-25 | $0.00 derived: sum of 3 quarters · filed 2024-03-25 | $1.38M 10-K · filed 2024-03-25 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $1.38M 10-Q · filed 2023-11-13 | $1.38M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.38M 10-Q · filed 2023-08-08 | $1.38M derived: sum of 3 quarters · filed 2023-08-08 | |
| 2022-03-31 | $1.38M 10-Q · filed 2023-05-11 | $1.38M derived: sum of 2 quarters · filed 2023-05-11 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $0.00 10-K · filed 2023-03-30 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |